GlaxoSmithKline: all 4,196 studies
Page 14 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic TreatmentCompletedNCT01235949Phase 4Results posted
- A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With InfluenzaCompletedNCT01231620Phase 3Results posted
- Dutasteride Versus Placebo and Finasteride in Men With Androgenetic AlopeciaCompletedNCT01231607Phase 3Results posted
- Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic CancerCompletedNCT01231581Phase 2Results posted
- Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)TerminatedNCT01231555Phase 2Results posted
- A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive AdultsCompletedNCT01231516Phase 3Results posted
- Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African InfantsCompletedNCT01231503Phase 2Results posted
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic RhinitisCompletedNCT01231464Phase 3Results posted
- Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian WomenCompletedNCT01227928Phase 2Results posted
- Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset SeizuresCompletedNCT01227902Phase 3Results posted
- A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) MelanomaCompletedNCT01227889Phase 3Results posted
- A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice DailyCompletedNCT01227824Phase 3Results posted
- Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade HistologiesCompletedNCT01224821Phase 2Results posted
- Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes MellitusTerminatedNCT01222078Phase 2Results posted
- Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast CancerTerminatedNCT01220128Phase 2Results posted
- A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in ChildrenCompletedNCT01218308Phase 3Results posted
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With AtorvastatinCompletedNCT01218204Phase 2Results posted
- Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT01218126Phase 2Results posted
- Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected PersonsCompletedNCT01218113Phase 2Results posted
- Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous MelanomaCompletedNCT01213472Phase 1Results posted
- GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure InfectionCompletedNCT01209078Phase 2Results posted
- A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb SpasticityCompletedNCT01205451Phase 3Results posted
- VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PKCompletedNCT01205230Phase 4Results posted
- An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)CompletedNCT01205165Phase 4Results posted
- Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)CompletedNCT01204671Phase 3Results posted
- Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy InfantsCompletedNCT01204658Phase 2Results posted
- Relenza® Sentinel Site Monitoring Program in JapanCompletedNCT01199744Results posted
- Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV InfectionTerminatedNCT01199731Phase 2Results posted
- Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.CompletedNCT01198769Phase 4Results posted
- A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in ChildrenCompletedNCT01198756Phase 3Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in ChildrenCompletedNCT01196988Phase 3Results posted
- A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in AdultsCompletedNCT01196975Phase 3Results posted
- Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™CompletedNCT01196026Phase 4Results posted
- Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy ChildrenTerminatedNCT01195779Phase 2Results posted
- A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPDCompletedNCT01192191Phase 3Results posted
- Fall Epidemic Viral Pediatric StudyCompletedNCT01192178Phase 4Results posted
- Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTMCompletedNCT01190215Phase 4Results posted
- Epidemiology Study of Malaria Transmission Intensity in AfricaCompletedNCT01190202Not applicableResults posted
- Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 StudyCompletedNCT01190189Phase 3Results posted
- Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study SubjectsCompletedNCT01190176Phase 3Results posted
- Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent AsthmaCompletedNCT01181895Phase 3Results posted
- A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)CompletedNCT01178073Phase 3Results posted
- Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850ACompletedNCT01175083Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster DoseCompletedNCT01171989Phase 2Results posted
- Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese InfantsCompletedNCT01171963Phase 3Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/AdultsCompletedNCT01165242Phase 2Results posted
- Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and OlderCompletedNCT01165229Phase 3Results posted
- Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected SubjectsCompletedNCT01165203Phase 2Results posted
- Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and OlderCompletedNCT01165177Phase 3Results posted
- Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent AsthmaticsCompletedNCT01165138Phase 3Results posted
- Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years OldCompletedNCT01161160Phase 2Results posted
- Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TMTerminatedNCT01160237Phase 3Results posted
- A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.CompletedNCT01160198Phase 3Results posted
- Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and AdolescentsCompletedNCT01159912Phase 3Results posted
- Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of AgeCompletedNCT01156792Phase 2Results posted
- Prophylactic Efficacy of Relenza Against Influenza A and BCompletedNCT01156701Results posted
- A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-DopaCompletedNCT01154166Phase 3Results posted
- Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type PsoriasisCompletedNCT01154101Phase 2Results posted
- Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year OldsCompletedNCT01154088Phase 3Results posted
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in NigeriaCompletedNCT01153893Phase 3Results posted
- Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in VietnamCompletedNCT01153841Phase 3Results posted
- A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb SpasticityCompletedNCT01153815Phase 3Results posted
- A Study of GSK2118436 in BRAF Mutant Metastatic MelanomaCompletedNCT01153763Phase 2Results posted
- Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 YearsCompletedNCT01153685Phase 3Results posted
- Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin CancerCompletedNCT01149343Phase 1Results posted
- Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and ChildrenCompletedNCT01148459Phase 3Results posted
- Evaluation of Boostrix™10 Years After Previous Booster VaccinationCompletedNCT01147900Phase 4Results posted
- HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsCompletedNCT01147848Phase 3Results posted
- Safety and Efficacy Study for Solid Tumor Patients Treated With EltrombopagCompletedNCT01147809Phase 2Results posted
- Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once DailyCompletedNCT01147744Phase 2Results posted
- Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib VaccinesCompletedNCT01144663Phase 3Results posted
- A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in AdultsCompletedNCT01144299Phase 3Results posted
- The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body PsoriasisCompletedNCT01139580Phase 3Results posted
- Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)CompletedNCT01138124Results posted
- Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated ChildrenCompletedNCT01138098Phase 4Results posted
- Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBCCompletedNCT01138046Phase 2Results posted
- A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)CompletedNCT01138007Phase 3Results posted
- Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular DegenerationCompletedNCT01134055Phase 2Results posted
- Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent AsthmaticsCompletedNCT01134042Phase 3Results posted
- Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental ErosionCompletedNCT01128972Phase 2Results posted
- Enamel Remineralization Potential of Dentifrices in SituCompletedNCT01128946Phase 4Results posted
- A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.CompletedNCT01128894Phase 3Results posted
- GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary HyperhidrosisCompletedNCT01128738Phase 3Results posted
- A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263CompletedNCT01128621Phase 2Results posted
- Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic ResponseCompletedNCT01128595Phase 2Results posted
- Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic ResponseCompletedNCT01128569Phase 2Results posted
- Lapatinib in Combination With VinorelbineCompletedNCT01128543Phase 2Results posted
- Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01124422Phase 4Results posted
- Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2CompletedNCT01123083Phase 3Results posted
- Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growthCompletedNCT01122862Phase 2Results posted
- Exploratory Subjective Sleep Study of a Prototype Nasal DilatorCompletedNCT01122849Phase 2Results posted
- A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and PharmacodynamicsCompletedNCT01119846Phase 2Results posted
- Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster DoseCompletedNCT01119625Phase 3Results posted
- Efficacy of Potassium Nitrate Solution in Reducing Dentinal HypersensitivityCompletedNCT01115452Phase 2Results posted
- Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or OlderCompletedNCT01114620Phase 4Results posted
- A Safety and Tolerability Study of Otelixizumab in Thyroid Eye DiseaseTerminatedNCT01114503Phase 2Results posted
- Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization StudyCompletedNCT01110200Phase 4Results posted
- Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy ToddlersCompletedNCT01106092Phase 2Results posted
- Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA)CompletedNCT01105936Phase 4Results posted
- A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)CompletedNCT01102972Phase 4Results posted